- Home
- ATOS vs TATT Comparison
ATOS vs TATT Comparison
Compare ATOS & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- TATT
- Stock Information
- Founded
- ATOS 2009
- TATT 1985
- Country
- ATOS United States
- TATT Israel
- Employees
- ATOS N/A
- TATT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- TATT Aerospace
- Sector
- ATOS Health Care
- TATT Industrials
- Exchange
- ATOS Nasdaq
- TATT Nasdaq
- Market Cap
- ATOS 174.8M
- TATT 209.6M
- IPO Year
- ATOS 2012
- TATT 1987
- Fundamental
- Price
- ATOS $1.19
- TATT $21.73
- Analyst Decision
- ATOS Strong Buy
- TATT
- Analyst Count
- ATOS 3
- TATT 0
- Target Price
- ATOS $6.75
- TATT N/A
- AVG Volume (30 Days)
- ATOS 738.2K
- TATT 35.0K
- Earning Date
- ATOS 11-12-2024
- TATT 11-18-2024
- Dividend Yield
- ATOS N/A
- TATT N/A
- EPS Growth
- ATOS N/A
- TATT 43.74
- EPS
- ATOS N/A
- TATT 0.76
- Revenue
- ATOS N/A
- TATT $142,909,000.00
- Revenue This Year
- ATOS N/A
- TATT N/A
- Revenue Next Year
- ATOS N/A
- TATT N/A
- P/E Ratio
- ATOS N/A
- TATT $29.52
- Revenue Growth
- ATOS N/A
- TATT 36.36
- 52 Week Low
- ATOS $0.70
- TATT $9.08
- 52 Week High
- ATOS $2.31
- TATT $24.29
- Technical
- Relative Strength Index (RSI)
- ATOS 31.91
- TATT 60.42
- Support Level
- ATOS $1.26
- TATT $18.87
- Resistance Level
- ATOS $1.66
- TATT $24.29
- Average True Range (ATR)
- ATOS 0.09
- TATT 1.48
- MACD
- ATOS -0.03
- TATT 0.27
- Stochastic Oscillator
- ATOS 4.08
- TATT 61.09
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About TATT TAT Technologies Ltd.
TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.